Venetoclax Is an Option in B‐cell Prolymphocytic Leukaemia Following Progression on B‐cell Receptor Pathway Inhibitors

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.15912
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy